I will jump in, and perhaps my colleague or Professor Everett would like to.
I don't have the global comparison, but I have been stating this all along, that investments in and in support of the life sciences sector and the innovative medicines industry have not been strong in Canada.
I would like to add, because I haven't had a chance to do so, that what we have seen in the last few months, the outreach from the current government to this industry, has been remarkable. To me, it's such a good news story for Canada of what can be. I can't help but think of what we might have left on the table in previous years and what might be ahead of us, so there is an optimism for me that the government will start embracing this industry and appreciate, not just that it's a cost centre in their eyes but a value centre as well.
We look forward to what the government will do going forward.